These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Virtual screening for the identification of novel inhibitors of Mycobacterium tuberculosis cell wall synthesis: inhibitors targeting RmlB and RmlC. Ren JX; Qian HL; Huang YX; Zhu NY; Si SY; Xie Y Comput Biol Med; 2015 Mar; 58():110-7. PubMed ID: 25637777 [TBL] [Abstract][Full Text] [Related]
27. Identification of the Seaweed Metabolites as Potential Anti-tubercular Agents Against Human Pantothenate synthetase: An In Silico Approach. Arokia Rajan MS; Thirunavukkarasu R; Joseph J; Palliyath GK; Somarathinam K; Kothandan G; Subaramaniyan K; Ullah R; Rajesh RP Curr Microbiol; 2023 Aug; 80(10):318. PubMed ID: 37578562 [TBL] [Abstract][Full Text] [Related]
28. Exploring the interaction mechanism between potential inhibitor and multi-target Mur enzymes of mycobacterium tuberculosis using molecular docking, molecular dynamics simulation, principal component analysis, free energy landscape, dynamic cross-correlation matrices, vector movements, and binding free energy calculation. Kumari M; Singh R; Subbarao N J Biomol Struct Dyn; 2022; 40(24):13497-13526. PubMed ID: 34662260 [TBL] [Abstract][Full Text] [Related]
30. Identifying the analogues of berberine as promising antitubercular drugs targeting Mtb-FtsZ polymerisation through ligand-based virtual screening and molecular dynamics simulations. Akinpelu OI; Kumalo HM; Mhlongo SI; Mhlongo NN J Mol Recognit; 2022 Feb; 35(2):e2940. PubMed ID: 34910337 [TBL] [Abstract][Full Text] [Related]
31. Identification of potential inhibitors of Kamera S; Sharma VK; Prasad V B; Garlapati A J Biomol Struct Dyn; 2023 Aug; ():1-15. PubMed ID: 37526169 [TBL] [Abstract][Full Text] [Related]
32. Refined homology model of cytochrome bcc complex B subunit for virtual screening of potential anti-tuberculosis agents. Pan Z; Wang Y; Gu X; Wang J; Cheng M J Biomol Struct Dyn; 2020 Oct; 38(16):4733-4745. PubMed ID: 31674290 [TBL] [Abstract][Full Text] [Related]
33. Discovery of new inhibitors of Mycobacterium tuberculosis EPSP synthase - A computational study. Dahmer BR; Ethur EM; Timmers LFSM J Mol Graph Model; 2023 Jun; 121():108404. PubMed ID: 36907015 [TBL] [Abstract][Full Text] [Related]
34. Computational discovery of potent drugs to improve the treatment of pyrazinamide resistant Mycobacterium tuberculosis mutants. Jagadeb M; Rath SN; Sonawane A J Cell Biochem; 2018 Sep; 119(9):7328-7338. PubMed ID: 29761826 [TBL] [Abstract][Full Text] [Related]
35. Structure-based drug design, synthesis and screening of MmaA1 inhibitors as novel anti-TB agents. Veeravarapu H; Malkhed V; Mustyala KK; Vadija R; Malikanti R; Vuruputuri U; Muthyala MKK Mol Divers; 2021 Feb; 25(1):351-366. PubMed ID: 32533514 [TBL] [Abstract][Full Text] [Related]
36. In Silico Identification of Possible Inhibitors for Protein Kinase B (PknB) of Vieira TF; Martins FG; Moreira JP; Barbosa T; Sousa SF Molecules; 2021 Oct; 26(20):. PubMed ID: 34684743 [TBL] [Abstract][Full Text] [Related]
37. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship. Tomioka H Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755 [TBL] [Abstract][Full Text] [Related]
38. Structure-based identification of natural compound inhibitor against Lata S; Akif M J Biomol Struct Dyn; 2021 Aug; 39(12):4480-4489. PubMed ID: 32567497 [TBL] [Abstract][Full Text] [Related]
39. Pharmacophore model-based virtual screening, docking, biological evaluation and molecular dynamics simulations for inhibitors discovery against Naz S; Farooq U; Khan S; Sarwar R; Mabkhot YN; Saeed M; Alsayari A; Muhsinah AB; Ul-Haq Z J Biomol Struct Dyn; 2021 Feb; 39(2):610-620. PubMed ID: 31937192 [TBL] [Abstract][Full Text] [Related]
40. An integrated computational approach of molecular dynamics simulations, receptor binding studies and pharmacophore mapping analysis in search of potent inhibitors against tuberculosis. Agarwal S; Verma E; Kumar V; Lall N; Sau S; Iyer AK; Kashaw SK J Mol Graph Model; 2018 Aug; 83():17-32. PubMed ID: 29753941 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]